Patrick J. Baker
Eli Lilly and Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Patrick J. Baker.
Pharmaceutical Research | 1989
Lee E. Kirsch; R. Michael Molloy; Manual Debono; Patrick J. Baker; Khadiga Z. Farid
Two degradation products of the lipopeptide antibiotic, daptomycin, were identified and the reaction pathway and kinetics were delineated in aqueous solution at 60°C, pH range 3 to 8 and ionic strength 0.01. The degradation products were 1) a succinimido intermediate (anhydro-daptomycin) formed by attack of side-chain carbonyl on the peptide-bond nitrogen in the asp–gly sequence and 2) a β-asp daptomycin isomer formed by rehydration of the anhydrodaptomycin succinimide. This aspartyl transpeptidation pathway was found to be reversible. Formation of the anhydrodaptomycin from either daptomycin or β-asp daptomycin was pH dependent but the pH–rate profiles for anhydrodaptomycin formation were not mechanistically interpretable. The pH–rate profiles for the formation of daptomycin or β-asp daptomycin from the anhydrodaptomycin were linear with slopes = 1, which is consistent with nucleophilic hydroxide ion attack of the succinimido intermediate at either the α-carbonyl, giving rise to the β-asp daptomycin, or the β-carbonyl, giving rise to daptomycin.
Tetrahedron | 1991
Dale R. Sanson; Hanna Gracz; Michael S. Tempesta; David S. Fukuda; Walter Mitsuo Nakatsukasa; Thomas H. Sands; Patrick J. Baker; Jon S. Mynderse
Compounds A82775B (1) and A82775C (2) were isolated as non-antimicrobial by-products during attempts to isolate an elusive G+, G- antibiotic from culture A82775. an unidentified mold. A82775 factors B and C are present in both the mycelium and filtered broth. The metabolites were recovered from the filtered broth by adsorption on Diaion HP-20 nonfunctionalized macroreticular resin and purified by preparative reverse phase HPLC on C18 bonded phase supports. The structure elucidation of A82775 factors B (1) and C (2) has been accomplished by spectroscopic means including COSY, NOESY, INAPT, HMQC and 2D-INADEQUATE NMR experiments.
The Journal of Antibiotics | 1990
David S. Fukuda; Jon S. Mynderse; Patrick J. Baker; Donnis M. Berry; Laverne Dwaine Boeck; Raymond C. Yao; Frederick P. Mertz; Walter Mitsuo Nakatsukasa; James A. Mabe; John L. Ott; F. T. Counter; P. W. Ensminger; Norris E. Allen; W. E. Alborn; J N Hobbs
Archive | 1991
Patrick J. Baker; Manuel Debono; Khadiga Z. Farid; R. Michael Molloy
The Journal of Antibiotics | 1985
Jon S. Mynderse; Susan K. Samlaska; David S. Fukuda; Rene H. Du Bus; Patrick J. Baker
Archive | 1988
Patrick J. Baker
Archive | 1994
Jon S. Mynderse; Patrick J. Baker; James A. Mabe; Jan R. Turner; Mary L. B. Huber; Mary C. Broughton; Walter Mitsuo Nakatsukasa; Lawrence Creemer; Herbert A. Kirst; James W. Martin
The Journal of Antibiotics | 1990
David S. Fukuda; R. H. Du Bus; Patrick J. Baker; Donnis M. Berry; Jon S. Mynderse
The Journal of Antibiotics | 1996
Herbert A. Kirst; Jon S. Mynderse; James W. Martin; Patrick J. Baker; Jonathan W. Paschal; Jorge Rios Steiner; Emil B. Lobkovsky; Jon Clardy
Archive | 1972
Patrick J. Baker